Shijiazhuang Yiling Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Shijiazhuang Yiling Pharmaceutical has a total shareholder equity of CN¥11.8B and total debt of CN¥1.6B, which brings its debt-to-equity ratio to 13.5%. Its total assets and total liabilities are CN¥17.4B and CN¥5.6B respectively. Shijiazhuang Yiling Pharmaceutical's EBIT is CN¥3.1B making its interest coverage ratio 121.7. It has cash and short-term investments of CN¥1.3B.
Key information
13.5%
Debt to equity ratio
CN¥1.60b
Debt
Interest coverage ratio | 121.7x |
Cash | CN¥1.31b |
Equity | CN¥11.85b |
Total liabilities | CN¥5.59b |
Total assets | CN¥17.44b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002603's short term assets (CN¥6.8B) exceed its short term liabilities (CN¥4.4B).
Long Term Liabilities: 002603's short term assets (CN¥6.8B) exceed its long term liabilities (CN¥1.2B).
Debt to Equity History and Analysis
Debt Level: 002603's net debt to equity ratio (2.5%) is considered satisfactory.
Reducing Debt: 002603's debt to equity ratio has increased from 0% to 13.5% over the past 5 years.
Debt Coverage: 002603's debt is well covered by operating cash flow (150.4%).
Interest Coverage: 002603's interest payments on its debt are well covered by EBIT (121.7x coverage).